Home › Funds › New York Life › NYLI Candriam U.S. Mid Cap Equity ETF
Fund family: New York Life · Filed by New York Life Investments ETF Trust (CIK 1415995) · SEC series S000077598
Ticker: IQSM (C000238086)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 2,407 with, 44 against, 0 abstentions (not counted as with management). Shareholder proposals: 35 FOR, 9 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as New York Life’s manager page (58,397 ballot items across 52 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | New York Life | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 91.4% | 2,327 | 92.5% | 47,807 |
| Backed environmental and social shareholder proposals at US companies | n/a | 10 | 14.2% | 772 |
Each ballot item this fund voted is set against the votes of the other New York Life funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most New York Life funds on 12 items (8.9% of the 135 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most New York Life funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Essential Utilities, Inc. | 2026-04-29 | To approve, on a non-binding and advisory basis, the compensation of the Company's named executive officers for 2025. | Against | FOR — 6 of 6 New York Life funds | Against | Approved, 90.2% support |
| IDEX Corporation | 2026-05-06 | Advisory vote to approve named executive officer compensation. | Against | FOR — 5 of 5 New York Life funds | Against | Passed (calculated), 88.6% support |
| IDEX Corporation | 2026-05-06 | Ratification of the appointment of Deloitte & Touche LLP as our independent registered accounting firm for 2026. | Against | FOR — 4 of 4 New York Life funds | Against | Passed (calculated), 85.8% support |
| The Toro Company | 2026-03-17 | Approval of, on an advisory basis, our executive compensation. | Against | FOR — 4 of 4 New York Life funds | Against | Passed (calculated), 94.3% support |
| AppFolio, Inc. | 2026-06-12 | Advisory vote to approve the compensation of our named executive officers. | Against | FOR — 4 of 4 New York Life funds | Against | Approved, 99.6% support |
| Nordson Corporation | 2026-03-02 | To approve, on an advisory basis, the compensation of our named executive officers; | Against | FOR — 3 of 3 New York Life funds | Against | Approved, 95.1% support |
| Dick's Sporting Goods, Inc. | 2026-06-10 | Non-binding advisory vote to approve compensation of named executive officers, as disclosed in the Company's 2026 proxy statement. | Against | FOR — 3 of 3 New York Life funds | Against | Passed (calculated), 99.1% support |
| Domino's Pizza, Inc. | 2026-04-21 | Advisory vote to approve the compensation of the named executive officers of the Company. | Against | FOR — 3 of 3 New York Life funds | Against | Approved, 94.0% support |
| Camden Property Trust | 2026-05-08 | Approval, by an advisory vote, of executive compensation. | Against | FOR — 3 of 3 New York Life funds | Against | Passed (calculated), 93.5% support |
| Federal Realty Investment Trust | 2026-05-06 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. | Against | FOR — 3 of 3 New York Life funds | Against | Passed (calculated), 93.5% support |
| Donaldson Company, Inc. | 2025-11-21 | Non-binding advisory vote on the compensation of our Named Executive Officers. | Against | FOR — 3 of 3 New York Life funds | Against | Approved, 93.6% support |
| F5, Inc. | 2026-03-12 | Approve the F5, Inc. 2026 Incentive Award Plan. | Against | FOR — 2 of 3 New York Life funds | Against | Passed (calculated), 66.8% support |
Download all 12 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 96.7% of this fund’s 2,451 such votes could be given a sector; the other 81 (3.3%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Consumer Discretionary | 590 | 20 | 3.4% |
| Industrials | 397 | 8 | 2.0% |
| Finance | 340 | 4 | 1.2% |
| Health Care | 312 | 2 | 0.6% |
| Technology | 263 | 5 | 1.9% |
| Real Estate | 227 | 1 | 0.4% |
| Consumer Staples | 126 | 2 | 1.6% |
| Utilities | 37 | 1 | 2.7% |
| Miscellaneous | 33 | 0 | 0.0% |
| Basic Materials | 17 | 0 | 0.0% |
| Telecommunications | 16 | 0 | 0.0% |
| Energy | 12 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 1,746 | 0 |
| Say-on-Pay | 252 | 0 |
| Audit-related | 234 | 0 |
| Corporate Governance | 106 | 30 |
| Compensation | 71 | 1 |
| Capital Structure | 29 | 0 |
| Extraordinary Transactions | 12 | 0 |
| Environment or Climate | 7 | 7 |
| Shareholder Rights and Defenses | 7 | 3 |
| Other Social Issues | 3 | 3 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Moderna, Inc. | May 6, 2026 | $9M | 5 | 0 |
| Revolution Medicines, Inc. | June 18, 2026 | $4M | 4 | 0 |
| Twilio Inc. | June 16, 2026 | $4M | 8 | 0 |
| United Therapeutics Corporation | June 26, 2026 | $3M | 15 | 0 |
| Tapestry, Inc. | November 13, 2025 | $3M | 12 | 0 |
| US Foods Holding Corp. | May 14, 2026 | $3M | 11 | 0 |
| XPO, Inc. | May 19, 2026 | $3M | 9 | 0 |
| Roku, Inc. | June 11, 2026 | $3M | 5 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| April 24, 2026 | Stanley Black & Decker, Inc. | To consider and vote on a shareholder proposal requesting an independent Board Chairman. Shareholder proposal | For | Against |
| May 8, 2026 | Masco Corporation | Consideration of stockholder proposal on shareholder right to call a special meeting. Shareholder proposal | For | Against |
| April 28, 2026 | Revvity, Inc. | To approve the shareholder proposal regarding Executives to Retain Significant Stock. Shareholder proposal | For | Against |
| May 21, 2026 | Assurant, Inc. | Stockholder proposal regarding action by written consent. Shareholder proposal | For | Against |
| June 1, 2026 | DocuSign, Inc. | A stockholder proposal to report on the risks of non-fiduciary executive compensation metrics, if properly presented at the meeting Shareholder proposal | Against | For |
| June 18, 2026 | BJ's Wholesale Club Holdings, Inc. | Vote on a shareholder proposal regarding adopting a majority voting standard, if properly presented at the meeting. Shareholder proposal | Against | For |
| June 18, 2026 | BJ's Wholesale Club Holdings, Inc. | Vote on a shareholder proposal regarding a report on greenhouse gas emissions reduction efforts, if properly presented at the meeting. Shareholder proposal | For | Against |
| June 16, 2026 | Five Below, Inc. | Shareholder proposal requesting that provisions in the Company's governance documents requiring greater than a simple majority shareholder vote be changed to a simple majority vote standard. Shareholder proposal | For | Against |
| May 15, 2026 | Medpace Holdings, Inc. | Stockholder proposal regarding giving shareholders an ability to call for a special shareholder meeting, if properly presented at the meeting. Shareholder proposal | For | Against |
| April 30, 2026 | Crown Holdings, Inc. | Consideration of a Shareholder proposal regarding Shareholder right to act by written consent. Shareholder proposal | For | Against |
| June 10, 2026 | Annaly Capital Management, Inc. | Advisory stockholder proposal to adopt the right to act by written consent. Shareholder proposal | For | Against |
| May 13, 2026 | Skyworks Solutions, Inc. | To approve a stockholder proposal regarding greenhouse gas emission reduction efforts report. Shareholder proposal | For | Against |
2,467 ballot items at 245 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, NYLI Candriam U.S. Mid Cap Equity ETF (IQSM) voted at 245 shareholder meetings of 239 companies, on 2,467 ballot items in all. Where management made a recommendation, the fund followed it on 98.2% of the items and voted against it 44 times. Its most frequent area of disagreement was corporate governance (30 of its votes against management). It voted on 44 shareholder proposals. It voted FOR the board's own proposals less often than New York Life's funds as a whole (91.4% against 92.5%). It voted differently from most New York Life funds on 12 items.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of New York Life’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.